Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ensem Therapeutics
Ensem Therapeutics
Atavistik Bio, Inc
Eli Lilly and Company
Boehringer Ingelheim
Novartis
GlaxoSmithKline
Exelixis
The Affiliated Hospital of Qingdao University
Novartis
Istituti Clinici Scientifici Maugeri SpA
AstraZeneca
AstraZeneca
Accelerated Community Oncology Research Network
AstraZeneca
Hellenic Oncology Research Group
AstraZeneca
AstraZeneca